Plasma lipids and betaine are related in an acute coronary syndrome cohort

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Lever, Michael ^a,b   George, Peter M ^a,b   Atkinson, Wendy ^a   Molyneux, Sarah L ^a   Elmslie, Jane L ^a   Slow, Sandy ^a,b   Richards, A Mark ^b   Chambers, Stephen T ^b  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; TRIACYLGLYCEROL; UBIQUINONE; ANTILIPEMIC AGENT; DIMETHYLGLYCINE; DRUG DERIVATIVE; SARCOSINE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; URINARY EXCRETION; URINE LEVEL; BLOOD; DIET SUPPLEMENTATION; METABOLISM; MIDDLE AGED; URINE;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BETAINE; COHORT STUDIES; DIABETES COMPLICATIONS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MIDDLE AGED; SARCOSINE;

EID: 79959794451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021666     Document Type: Article

References (37)

1. Zeisel SH, Mar MH, Howe JC, Holden JM, (2003) Concentrations of choline-containing compounds and betaine in common foods. J Nutr133: 1302-1307.
2. de Zwart FJ, Slow S, Payne RJ, Lever M, George PM, et al. (2003) Glycine betaine and glycine betaine analogues in common foods. Food Chem 83: 197-204.
3. Lever M, Slow S, (2010) The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem 43: 732-744.
4. Ueland PM, (2011) Choline and betaine in health and disease. J Inherit Metab Dis 34: 3-15.
5. Eklund M, Bauer E, Wamatu J, Mosenthin R, (2005) Potential nutritional and physiological functions of betaine in livestock. Nutr Res Rev 18 pp. 31-48.
6. Ratriyanto A, Mosenthin R, Bauer E, Eklund M, (2009) Metabolic, osmoregulatory and nutritional functions of betaine in monogastric animals. Asian-Austral J Animal Sci 22: 1461-1476.
7. Hayes KC, Pronczuk A, Cook, MW, Robbins MC, (2003) Betaine in sub-acute and sub-chronic rat studies. Food Chem Toxicol 41: 1685-1700.
8. Schwahn BC, Wang X-L, Mikael LG, Wua Q, Cohn J, et al. (2007) Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. Atherosclerosis 195: e100-107.
9. Lv S, Hou M, Tang Z, Ling W, Zhu H, (2009) Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice. Eur J Nutr 48: 205-212.
10. Kim S-H, Yang S-O, Kim H-S, Kim Y, Park T, et al. (2009) 1H-nuclear magnetic resonance spectroscopy-based metabolic assessment in a rat model of obesity induced by a high-fat diet. Anal Bioanal Chem 395: 1117-1124.
11. Kim H-J, Kim JH, Noh S, Hur HJ, Sung MJ, et al. (2011) Metabolomic analysis of livers and serum from high-fat diet induced obese mice J Proteome Res in press. DOI:10.1021/pr100892r.
12. Schwab U, Törrönen A, Toppinen L, Alfthan G, Saarinen M, et al. (2002) Betaine supplementation decreases plasma homocysteine concentrations but does not affect body weight, body composition, or resting energy expenditure in human subjects. Am J Clin Nutr 76: 961-967.
13. Olthof MR, van Vliet T, Verhoef P, Zock PL, Katan MB, (2005) Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans. PLoS Med 2: e135.
14. Schwab U, Alfthan G, Aro A, Uusitupa M, (2010) Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr 1-7.
15. Konstantinova SV, Tell GS, Vollset SE, Nygård O, Bleie Ø, et al. (2008) Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr 138: 914-920.
16. Lever M, George PM, Dellow WJ, Scott RS, Chambers ST, (2005) Homocysteine, glycine betaine, and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism 54: 1-14.
17. Lever M, Atkinson W, George PM, Chambers ST, (2007) Sex differences in the control of plasma concentrations and urinary excretion of glycine betaine in patients attending a lipid disorders clinic. Clin Biochem 40: 1225-1231.
18. De Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, et al. (2001) The prognostic value of B-type natriuretic peptides in patients with acute coronary syndromes. New Engl Med J 345: 1014-1021.
19. Storer MK, McEntyre CJ, Lever M, (2006) Separation of cationic aracyl derivatives of betaines and related compounds. J Chromatogr A 1104: 263-271.
20. Storer MK, Lever M, (2006) Aracyl triflates for preparing fluorescent and UV absorbing derivatives of unreactive carboxylates, amines and other metabolites. Anal Chim Acta 558: 319-325.
21. Molyneux SL, Florkowski CM, McGrane Y, Lever M, George PM, (2007) Concentration response to the coenzyme Q10 supplement Q-Gel in human volunteers. Nutr Res 27: 307-312.
22. Wang YZ, Xu ZR, Feng J, (2004) The effect of betaine and DL-methionine on growth performance and carcass characteristics in meat ducks. Anim Feed Sci Tech 116: 151-159.
23. Zhan XA, Li JX, Xu ZR, Zhao RQ, (2006) Effects of methionine and betaine supplementation on growth performance, carcase composition and metabolism of lipids in male broilers. Br Poultry Sci 47: 576-580.
24. Zeisel SH, (2006) Betaine Supplementation and Blood Lipids: Fact or Artifact? Nutrition Rev 64: 77-79.
25. Price RK, Keaveney EM, Hamill LL, Wallace JMW, Ward M, et al. (2010) Consumption of Wheat Aleurone-Rich Foods Increases Fasting Plasma Betaine and Modestly Decreases Fasting Homocysteine and LDL-Cholesterol in Adults. J Nutr 140: 2153-2157.
26. Lever M, Sizeland PC, Frampton CM, Chambers ST, (2004) Short and long-term variation of plasma glycine betaine concentrations in humans. Clin Biochem 37: 184-190.
27. Lever M, Atkinson W, Slow S, Chambers ST, George PM, (2009) Plasma and urine betaine and dimethylglycine variation in healthy young male subjects. Clin Biochem 42: 706-712.
28. Sparks JD, Collins HL, Chirieac DV, Cianci J, Jokinen J, et al. (2006) Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase. Biochem J 395: 363-371.
29. Martins JM, Neves JA, Freitas A, Tirapicos JL, (2010) Betaine supplementation affects the cholesterol but not the lipid profile of pigs. Eur J Lipid Sci Technol 112: 295-303.
30. Hwang YH, Hur SJ, Park GB, Joo ST, (2010) Effects of dietary glycine betaine on blood characteristics and pork quality. J Muscle Foods 21: 87-101.
31. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472: 57-63.
32. Zhang AQ, Mitchell SC, Smith RL, (1999) Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol 37: 515-520.
33. Slow S, Lever M, Chambers ST, George PM, (2009) Plasma dependent and independent accumulation of betaine in male and female rat tissues. Physiol Res 58: 403-10.
34. Liao JK, Laufs U, (2005) Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol 45: 89-118.
35. Lever M, George PM, Slow S, Elmslie JL, Scott RS, et al. (2009) Fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine. Cardiovasc Drugs Ther 23: 395-401.
36. Danne O, Möckel M, (2010) Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev Mol Diagn 10: 159-171.
37. Strakova J, Williams KT, Gupta S, Schalinske KL, Kruger WD, et al. (2010) Dietary intake of S-(α-carboxybutyl)-DL-homocysteine induces hyperhomocysteinemia in rats. Nutr Res 30: 492-500.